Singapore markets closed

Trevi Therapeutics, Inc. (TRVI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.7700-0.0700 (-2.46%)
At close: 04:00PM EDT
2.7700 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 200.04M
Enterprise value 128.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.77
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.49

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 318.33%
S&P500 52-week change 326.36%
52-week high 34.0000
52-week low 30.9700
50-day moving average 33.0048
200-day moving average 32.1184

Share statistics

Avg vol (3-month) 3259.77k
Avg vol (10-day) 3115.52k
Shares outstanding 570.44M
Implied shares outstanding 670.44M
Float 840.83M
% held by insiders 11.26%
% held by institutions 177.84%
Shares short (30 Apr 2024) 41.05M
Short ratio (30 Apr 2024) 44.2
Short % of float (30 Apr 2024) 42.45%
Short % of shares outstanding (30 Apr 2024) 41.50%
Shares short (prior month 28 Mar 2024) 41.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-24.56%
Return on equity (ttm)-38.57%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -38.13M
Net income avi to common (ttm)-33.57M
Diluted EPS (ttm)-0.3400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)72.82M
Total cash per share (mrq)1.03
Total debt (mrq)1.27M
Total debt/equity (mrq)1.76%
Current ratio (mrq)14.55
Book value per share (mrq)1.05

Cash flow statement

Operating cash flow (ttm)-33.98M
Levered free cash flow (ttm)-22.58M